Layoff season continues

Share this article:

Layoffs abound.

The fourth-quarter layoff tradition continues. Below, a mini roundup:

Actavis is laying off 30% of its sales staff, having assessed post-Warner Chilcott needs. The deal closed Oct. 1, and Actavis said 350 employees drawn from its sales force, district managers, account managers and management are losing their jobs.

Bayer is releasing 50 employees. Pharmalot found the news in a California filing about the closure of a Sunnyvale, CA, plant associated with its discontinued diabetes monitors A1CNow and A1CNowSelfCheck.

These layoffs come on top of other reorganizations, such as Shire's R&D cuts in Basingstoke, UK; Novartis's pink slipping of California-based researchers; and Merck's layoff of 8,500 workers.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.